1-4 of 4
Rebecca L. King
Close
Sort by
Journal Articles

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

Clinical Trials & Observations
Sanjal H. Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L. King, Matthew J. Maurer, James R. Cerhan, Andrew L. Feldman, Umar Farooq, Eric Mou, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6180–6186.
https://doi.org/10.1182/bloodadvances.2022007569
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients

Clinical Trials & Observations
Marissa Li, Moritz Binder, Terra Lasho, Alejandro Ferrer, Naseema Gangat, Aref Al-Kali, Abhishek Mangaonkar, Michelle Elliott, Mark Litzow, William Hogan, Animesh Pardanani, Alexandra Wolanskyj-Spinner, Matthew Howard, Rebecca L. King, Mithun Shah, Hassan Alkhateeb, Kebede Begna, Ayalew Tefferi, Christy Finke, Jennifer Oliveira, Rhett Ketterling, Horatiu Olteanu, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2272–2278.
https://doi.org/10.1182/bloodadvances.2020003976
Published: 2021
Includes: Supplemental data
Journal Articles

IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis

Clinical Trials & Observations
Surbhi Sidana, Surendra Dasari, Taxiarchis V. Kourelis, Angela Dispenzieri, David L. Murray, Rebecca L. King, Ellen D. McPhail, Marina Ramirez-Alvarado, Shaji K. Kumar, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2101–2105.
https://doi.org/10.1182/bloodadvances.2020003671
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era

Clinical Trials & Observations
Arushi Khurana, Mattia Novo, Grzegorz S. Nowakowski, Kay M. Ristow, Robert J. Spinner, Christopher H. Hunt, Rebecca L. King, Daniel H. Lachance, Thomas M. Habermann, Ivana N. Micallef, Patrick B. Johnston
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1379–1387.
https://doi.org/10.1182/bloodadvances.2020003666
Published: 2021
Includes: Supplemental data